DELFINA NEWSOME: Open Payments
NPI 1467886705 · SOUTH WILLIAMSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 33 payments from 15 companies in 2025. Trend: 2023 $623 · 2024 $610 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| ABBVIE INC. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $68 |
| Novo Nordisk Inc | 3 | $59 |
| Biogen, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $30 |
| Dexcom, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: KESIMPTA, CAPLYTA, JOURNAVX, Rybelsus, QULIPTA, LEQEMBI, Dexcom G6 Transmitter, HYQVIA.
Industry payments across KY — which companies pay providers there.
